Researchers from all the life sciences are turning their attention to the pandemic, and the CRISPR community is no exception. The latest CRISPR Journal‘s editorial presents a few of the projects that are showing promise, and others are probably going on. Kevin Davies and Rodolphe Barrangou also comment on the cancellation or postponement of several key conferences in the next few months due to Covid-19, especially the CRISPR 2020 meeting in Paris. They applaud all the scientists who are battling this disease in myriad ways and promise: we’ll meet again.
The DNA double helix as a metaphor for the relationship between genetics and SciFi – novels and movies on the one strand and scientific breakthroughs on the other strand. It’s courtesy of graduated student Kartik Lakshmi Rallapalli, who examines the science and fiction timelines in a post for the Addgene blog.Continue reading
CRISPR-pioneer Rodolphe Barrangou offers ten bold (and rosy) predictions for the next 12 months in his editorial for The CRISPR Journal. We fervently hope he is right! Please see our summary below.Continue reading
Great piece of science by the Liu Lab in Nature, describing the brand new “Search-and-replace genome editing without double-strand breaks or donor DNA”. How is the CRISPR community reacting?
Best quote: “One of those ‘Yay, science!!!’ kind of moments” (Fyodor Urnov quoted in Science)
Most ironic: “Congratulations @davidrliu. We’d probably have published this paper as well (The CRISPR Journal tweet)
Best title: Genome Editing Heads to Primetime (Genetic Engineering and Biotechnology News)
Most understated: A New Gene Editing Tool Could Make CRISPR More Precise (Smithsonian Mag)
Most hyped: A New CRISPR Technique Could Fix Almost All Genetic Diseases (Wired)
Don’t miss the “Draft Ethical Principles for Therapeutic Assisted Reproductive Technologies” just published by He Jiankui et al. in The CRISPR Journal. It seems the Lulu and Nana’s experiment is at odds even with their own guidelines. We are eager to hear more from He’s voice, his talk in Hong Kong is scheduled on Wednesday, 28 November 2018 (Second International Summit on Human Genome Editing-live broadcast)
BioArt is entering the genome-editing era. The first CRISPR artwork is a World War II dress, patched with silk and bacteria by British bioartist Anna Dumitriu. You can read more about its science and meaning in the CRISPR Journal and Labiotech. But where does the dress come from? And if this is art indeed, what about the galloping horse CRISPRed by George Church last year? I asked Dumitriu, please find the answers below. Continue reading
“As of January 2018 Addgene has distributed more than 100,000 CRISPR plasmids to 3,400 laboratories worldwide. More than 6,300 CRISPR-related plasmids have been developed by over 330 academic labs and deposited into Addgene’s collection. Geographically, new CRISPR plasmids have been developed and deposited to Addgene’s collection from the Americas (led by the United States), Europe (led by Denmark), Asia (led by China), and Oceania (led by Australia), and shipped to some 75 countries.” [Reference: Enabling the Rise of a CRISPR World, Caroline M. LaManna and Rodolphe Barrangou, The CRISPR Journal, Vol. 1, n. 3, 2018]
More than 60 germline ethics statements have been released by the international community so far (Italy is not included in the figure). Carolyn Brokowski, from the Yale School of Medicine, read and analyzed them all in The CRISPR Journal. A glance at her pie chart reveals a snapshot of the experts’ opinions on the moral permissibility of heritable genome editing. Continue reading
When you hear the word GMOs, chances are high that you think of plants, not animals. In the last 20 years, indeed, the Frankenfood controversy has forestalled the use of genetic engineering in animal breeding. To date, only a single food animal can be eaten in a single country (the fast-growing AquAdvantage salmon approved in Canada), while transgenic plants are grown on more than 180 million hectares in over twenty countries. Genome editing is now knocking at animal farms, will the door open? Continue reading